InferMed appoints Cancer Research UK's Dr Sally Burtles as Observer to the Board
InferMed has a long-standing relationship with Cancer Research UK, and was backed by the charity at its formation in 1999. A research relationship continues with Cancer Research UK, which remains InferMed's largest institutional shareholder.